Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Ranbaxy Labs
Ranbaxy Labs
BSE: 500359NSE: RANBAXYISIN: INE015A01028

25th-Feb-2013 11:53Source: BSE

Ranbaxy Labs - Update on Atorvastatin Recall

In Nov 2012, Ranbaxy Pharmaceuticals Inc., the US subsidiary of Ranbaxy, had initiated a voluntary recall for select batches and strengths of Atorvastatin calcium tablets only in the USA. However, Ranbaxy continues to supply this product in other markets across the world.

More Announcements on:

1 2 3 4 5 Next >>
Sections
Follow us on
Available On